181 related articles for article (PubMed ID: 6363908)
21. The mouse liver tumor as an endpoint in carcinogenesis tests.
Ward JM; Griesemer RA; Weisburger EK
Toxicol Appl Pharmacol; 1979 Dec; 51(3):389-97. PubMed ID: 395721
[No Abstract] [Full Text] [Related]
22. The parallelogram approach in studies of genotoxic effects.
Anderson D; Sorsa M; Waters MD
Mutat Res; 1994; 313(2-3):101-15. PubMed ID: 7523897
[TBL] [Abstract][Full Text] [Related]
23. Hepatocellular neoplasms in rats induced by butylated hydroxytoluene (BHT).
Olsen P; Bille N; Meyer O
Acta Pharmacol Toxicol (Copenh); 1983 Nov; 53(5):433-4. PubMed ID: 6659972
[No Abstract] [Full Text] [Related]
24. Molecular profiling of non-genotoxic hepatocarcinogenesis using differential display reverse transcription-polymerase chain reaction (ddRT-PCR).
Rockett JC; Esdaile DJ; Gibson GG
Eur J Drug Metab Pharmacokinet; 1997; 22(4):329-33. PubMed ID: 9512930
[TBL] [Abstract][Full Text] [Related]
25. DNA damage and repair tests for the detection of genotoxic agents.
Williams GM
Food Addit Contam; 1984; 1(2):173-8. PubMed ID: 6536528
[TBL] [Abstract][Full Text] [Related]
26. Comparison of the expression profiles induced by genotoxic and nongenotoxic carcinogens in rat liver.
Ellinger-Ziegelbauer H; Stuart B; Wahle B; Bomann W; Ahr HJ
Mutat Res; 2005 Aug; 575(1-2):61-84. PubMed ID: 15890375
[TBL] [Abstract][Full Text] [Related]
27. [Genotoxic effects of tonarol].
Karamova NS; Il'inskaia ON; Ivanchenko OB; Ermolaev AI; Gil'mutdinov GZ; Gershanov FB; Khamitov BR
Genetika; 1997 Sep; 33(9):1310-2. PubMed ID: 9445825
[TBL] [Abstract][Full Text] [Related]
28. Review of the mutagenicity/genotoxicity of butylated hydroxytoluene.
Bomhard EM; Bremmer JN; Herbold BA
Mutat Res; 1992 Sep; 277(3):187-200. PubMed ID: 1381049
[TBL] [Abstract][Full Text] [Related]
29. Hepatic microRNA profiles offer predictive and mechanistic insights after exposure to genotoxic and epigenetic hepatocarcinogens.
Koufaris C; Wright J; Currie RA; Gooderham NJ
Toxicol Sci; 2012 Aug; 128(2):532-43. PubMed ID: 22584684
[TBL] [Abstract][Full Text] [Related]
30. International Commission for Protection Against Environmental Mutagens and Carcinogens. ICPEMC publication No. 16. Testing for mutagens and carcinogens; the role of short-term genotoxicity assays.
Mutat Res; 1988; 205(1-4):3-12. PubMed ID: 3285192
[TBL] [Abstract][Full Text] [Related]
31. Quantitative assessment of cumulative carcinogenic risk for multiple genotoxic impurities in a new drug substance.
Bercu JP; Hoffman WP; Lee C; Ness DK
Regul Toxicol Pharmacol; 2008 Aug; 51(3):270-7. PubMed ID: 18550240
[TBL] [Abstract][Full Text] [Related]
32. Phenobarbital and related compounds: approaches to interspecies extrapolation.
Rice JM; Diwan BA; Ward JM; Nims RW; Lubet RA
Prog Clin Biol Res; 1992; 374():231-49. PubMed ID: 1620706
[No Abstract] [Full Text] [Related]
33. Mouse liver tumors and microsomal enzyme-inducing drugs: experimental and clinical perspectives with phenobarbital.
McClain RM
Prog Clin Biol Res; 1990; 331():345-65. PubMed ID: 2156272
[No Abstract] [Full Text] [Related]
34. A structural analysis of the genotoxic and carcinogenic potentials of cyclosporin A.
Rosenkranz HS; Klopman G
Mutagenesis; 1992 Mar; 7(2):115-8. PubMed ID: 1579066
[TBL] [Abstract][Full Text] [Related]
35. Mechanism of potentiation by caffeine of genotoxic damage induced by physical and chemical agents.
Roberts JJ
Nucleic Acids Symp Ser; 1984; (13):193-215. PubMed ID: 6493988
[No Abstract] [Full Text] [Related]
36. SOS chromotest results in a broader context: empirical relationships between genotoxic potency, mutagenic potency, and carcinogenic potency.
White PA; Rasmussen JB
Environ Mol Mutagen; 1996; 27(4):270-305. PubMed ID: 8665872
[TBL] [Abstract][Full Text] [Related]
37. Discrimination of genotoxic and non-genotoxic hepatocarcinogens by statistical analysis based on gene expression profiling in the mouse liver as determined by quantitative real-time PCR.
Watanabe T; Suzuki T; Natsume M; Nakajima M; Narumi K; Hamada S; Sakuma T; Koeda A; Oshida K; Miyamoto Y; Maeda A; Hirayama M; Sanada H; Honda H; Ohyama W; Okada E; Fujiishi Y; Sutou S; Tadakuma A; Ishikawa Y; Kido M; Minamiguchi R; Hanahara I; Furihata C
Mutat Res; 2012 Sep; 747(2):164-75. PubMed ID: 22634710
[TBL] [Abstract][Full Text] [Related]
38. Mouse liver tumor data: assessment of carcinogenic activity.
Pereira MA
Toxicol Ind Health; 1985 Dec; 1(4):311-33. PubMed ID: 3843510
[TBL] [Abstract][Full Text] [Related]
39. Identification of tumor promoters by their inhibitory effect on intercellular transfer of lucifer yellow.
Budunova IV; Mittelman LA; Belitsky GA
Cell Biol Toxicol; 1989 Jan; 5(1):77-89. PubMed ID: 2493319
[TBL] [Abstract][Full Text] [Related]
40. Genetic toxicity assessment: employing the best science for human safety evaluation. Part I: Early screening for potential human mutagens.
Jacobson-Kram D; Contrera JF
Toxicol Sci; 2007 Mar; 96(1):16-20. PubMed ID: 17194803
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
